House Bill Signals the End of NIH's Double-Digit Growth

+ See all authors and affiliations

Science  27 Jun 2003:
Vol. 300, Issue 5628, pp. 2019
DOI: 10.1126/science.300.5628.2019a

You are currently viewing the summary.

View Full Text


It may be crunch time for the National Institutes of Health (NIH), judging by Congress's first action on the 2004 biomedical budget. NIH has seen a series of double-digit increases over the past 5 years, but a House of Representatives appropriations subcommittee last week marked up a bill that would give NIH a rise of only 2.5%--to $27.7 billion--signaling an abrupt halt to the expansion. Biomedical research advocates are hoping that the Senate, which begins work on its own bill this week, will scrape up more money.